| mRNA |
dabrafenib |
CTRPv2 |
pan-cancer |
AAC |
0.27 |
2e-09 |
| mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
2e-07 |
| mRNA |
PLX4720 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
1e-06 |
| mRNA |
IU1 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
2e-06 |
| mRNA |
GDC-0879 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
1e-05 |
| mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
5e-05 |
| mRNA |
CID-5951923 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
6e-05 |
| mRNA |
etoposide |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.0001 |
| mRNA |
tacrolimus |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0002 |
| mRNA |
GSK1120212 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
0.0002 |